RxDoctor Payments DataLook up a doctor →

Natesto: payments to doctors

Payments that named Natesto as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$638K
Providers
5,580
Transactions
12,949
Average per transaction
$49

The per-transaction average — $49 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,580 providers the average total is $114, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Acerus Pharmaceuticals Corporation$406,94163.8%
Aytu Bioscience, Inc$227,17935.6%
Aytu Biopharma, Inc.$4,0930.6%
Endo Pharmaceuticals Inc.$170.0%
← All drugs & devices